Parkinson Disease Panel NGS Genetic Test sale cost 4400 AED
Mitochondrial Mutation Detection Comprehensive Panel Test sale cost 5620 AED Mitochondrial Mutation Detection Comprehensive Panel Test Cost 6,240 د.إ Original price was: 6,240 د.إ.5,620 د.إCurrent price is: 5,620 د.إ.
Growth Hormone Releasing Hormone GHRH Test sale cost 5310 AED Growth Hormone Releasing Hormone GHRH Test Cost 5,900 د.إ Original price was: 5,900 د.إ.5,310 د.إCurrent price is: 5,310 د.إ.
Sale!

Parkinson Disease Panel NGS Genetic Test Cost

Original price was: 6,000 د.إ.Current price is: 4,400 د.إ.

-27%

The Parkinson Disease Panel NGS (Next Generation Sequencing) Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with Parkinson’s disease. This advanced test uses cutting-edge sequencing technology to analyze multiple genes simultaneously, providing insights into the genetic predisposition and potential risk factors for developing Parkinson’s disease. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, accurate results. By detecting specific genetic variations, this test can help in the early diagnosis of Parkinson’s disease, enabling timely intervention and personalized treatment plans to manage symptoms and improve quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Parkinson Disease Panel NGS Genetic Test

Test Name: Parkinson Disease Panel NGS Genetic DNA Test

Components Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for Parkinson Disease Panel NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Parkinson Disease Panel.

Test Details

The Parkinson Disease Panel NGS Genetic DNA Test is a diagnostic test that uses next-generation sequencing (NGS) technology to analyze multiple genes associated with Parkinson’s disease. This test is designed to identify genetic mutations or variants that may increase the risk of developing Parkinson’s disease or contribute to the development of the disease in individuals who have already been diagnosed.

The Parkinson Disease Panel NGS Genetic DNA Test typically includes analysis of genes such as SNCA, LRRK2, PARK2, PINK1, and DJ-1, among others. These genes are known to play a role in the development and progression of Parkinson’s disease, and mutations or variants in these genes can increase an individual’s risk of developing the disease.

The test is typically performed on a blood or saliva sample, and results are typically available within a few weeks. If genetic mutations or variants are identified, the results can be used to guide treatment and management strategies for individuals with Parkinson’s disease, as well as to inform genetic counseling and family planning decisions.

 

Test Name Parkinson disease panel NGS Genetic DNA Test
Components  
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for Parkinson disease panel NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Parkinson disease panel
Test Details

The Parkinson disease panel NGS genetic DNA test is a diagnostic test that uses next-generation sequencing (NGS) technology to analyze multiple genes associated with Parkinson’s disease. This test is designed to identify genetic mutations or variants that may increase the risk of developing Parkinson’s disease or contribute to the development of the disease in individuals who have already been diagnosed.

The Parkinson disease panel NGS genetic DNA test typically includes analysis of genes such as SNCA, LRRK2, PARK2, PINK1, and DJ-1, among others. These genes are known to play a role in the development and progression of Parkinson’s disease, and mutations or variants in these genes can increase an individual’s risk of developing the disease.

The test is typically performed on a blood or saliva sample, and results are typically available within a few weeks. If genetic mutations or variants are identified, the results can be used to guide treatment and management strategies for individuals with Parkinson’s disease, as well as to inform genetic counseling and family planning decisions.
SKU: TEST-847 Category:

Related products